Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.995 USD | +6.18% | +21.32% | -8.81% |
May. 20 | HC Wainwright Starts Coverage on Prime Medicine With Buy Rating, $10 Price Target | MT |
May. 17 | North American Morning Briefing : The "Everything -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.81% | 871M | |
+8.25% | 115B | |
+13.17% | 107B | |
-13.40% | 22.31B | |
-3.99% | 21.6B | |
-5.63% | 18.23B | |
-39.93% | 17.62B | |
+7.49% | 14.26B | |
+33.73% | 12.37B | |
-28.15% | 8.28B |
- Stock Market
- Equities
- PRME Stock
- News Prime Medicine, Inc.
- Wedbush Initiates Prime Medicine With Outperform Rating, $12 PT; Notes Positive Long-Term Outlook on Gene Editing Platform